Susquehanna International Group, LLP Intercept Pharmaceuticals, Inc. Put Options Transaction History

Susquehanna International Group, LLP

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2023 Nov 14, 2023	BUY	$9.99 - $18.71 $243,756 - $456,524	24,400 Added 13.38%	206,700 $3.83 Million
Q2 2023 Aug 11, 2023	SELL	$9.17 - $19.29 $1.01 Million - $2.12 Million	-109,800 Reduced 37.59%	182,300 $2.02 Million
Q1 2023 May 16, 2023	BUY	$12.53 - $21.71 $1.46 Million - $2.54 Million	116,900 Added 66.72%	292,100 $3.92 Million
Q4 2022 Feb 14, 2023	SELL	$11.61 - $16.11 $1.82 Million - $2.53 Million	-156,800 Reduced 47.23%	175,200 $2.17 Million
Q3 2022 Nov 14, 2022	BUY	$12.21 - $19.7 $2.64 Million - $4.26 Million	216,300 Added 186.95%	332,000 $4.63 Million

1.04M

30K

5.9K

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.